Telix gets FDA Fast Track for BiPASS pre-biopsy prostate imaging programSep 29Regulatory milestoneTelix Pharmaceuticals Ltd
FDA approves Telix's Pixclara for glioma imagingSep 14Regulatory decisionfloretyrosine f 18Telix Pharmaceuticals Ltd
Telix finishes enrollment in Phase 3 BiPASS trial, aligns with FDA on NDA pathSep 1Clinical readoutTelix Pharmaceuticals Ltd
Sign inSign in